Stocks
ALX Oncology Holdings (ALXO) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 4.35 | 2.08 | 1.05 | 0.84 | 0.40 | 1.53 | |||
| Changes by years, y/y, % | -56% | -52% | -50% | -20% | -52% | -47.5% | |||
ALX Oncology Holdings. Debt/EBITDA
ALX Oncology Holdings. Debt/EBITDA, changes, %
ALX Oncology Holdings (ALXO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.69 | 0.55 | 0.53 | 0.40 | 1.56 | 1.53 | ||
| Changes by years, y/y, % | -20% | -33% | -43% | -55% | +126% | |||
| Changes by quarters, q/q, % | -23% | -20% | -4% | -25% | +291% | |||
